Actavis - Wikipedia
WEBActavis Generics [1] (formerly known as Watson Pharmaceuticals and Actavis plc, prior to the acquisition of Irish-based Allergan, Inc.) is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products.
Teva Completes Acquisition of Actavis Generics
WEBAug 2, 2016 · Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Allergan plc (NYSE: AGN) today announced that Teva has completed its acquisition of Allergan’s generics business (“Actavis Generics”). This strategic acquisition brings together two leading generics businesses with complementary …
Watson Pharmaceuticals, Inc. is Now Actavis, Inc. - PR Newswire
WEBJan 24, 2013 · Actavis, Inc. (NYSE: ACT) is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The Company has ...
Actavis to Acquire Allergan to Create Top 10 Global Growth ...
WEBNov 23, 2014 · Actavis. shares for each share of . Allergan. common stock. Based on the closing price of . Actavis. shares on . November 14, 2014, the transaction is valued at approximately . $66 billion, or . $219. per . Allergan. share. The combination will create one of the top 10 global pharmaceutical companies …
Actavis (now Allergan) - LinkedIn
WEBSpecialties Generic Pharmaceuticals, Branded Pharmaceuticals, Over-the-Counter Pharmaceuticals, and Biologics
Teva Completes Actavis Acquisition and Picks Up Anda, Inc ...
WEBAug 3, 2016 · Teva Pharmaceutical Industries has completed its acquisition of Allergan’s Actavis Generics business for $40.5 billion. Teva had announced its plans to acquire Actavis in 2015, but the Federal Trade Commission had required that the Israeli company first divest 79 of its generics businesses in such areas as anesthetics, antibiotics, weight loss treatments, and oral contraceptives.
Skip to content